CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Short Interest Up 10.3% in December

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) saw a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 20,300 shares, an increase of 10.3% from the December 15th total of 18,400 shares. Based on an average trading volume of 163,500 shares, the short-interest ratio is currently 0.1 days.

CERo Therapeutics Stock Performance

Shares of NASDAQ:CEROW traded up $0.00 during midday trading on Friday, hitting $0.02. 37,939 shares of the stock traded hands, compared to its average volume of 290,885. CERo Therapeutics has a one year low of $0.00 and a one year high of $0.25. The business’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.01.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.